Zacks: Brokerages Expect Allscripts Healthcare Solutions Inc. (MDRX) will book Quarterly Sales of $ 545.90 million



Wall Street brokers expect Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) to announce $ 545.90 million in revenue for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have made estimates for the revenues of Allscripts Healthcare Solutions, with estimates ranging from $ 520.38 million to $ 552.90 million. Allscripten Healthcare Solutions reported sales of $ 451.20 million in the same quarter last year, which would indicate positive annual growth of 21%. The company is scheduled to release its next profit results on Thursday, November 1.

According to Zacks, analysts expect Allscripts Healthcare Solutions to report an annual revenue of $ 2.17 billion for the current fiscal year, with estimates ranging from $ 2.16 billion to $ 2.21 billion. For the next financial year, analysts predicted that the company would generate sales of $ 2.26 billion per share, with estimates ranging from $ 2.17 billion to $ 2.29 billion. The sales calculations of Zacks are an average average based on a survey of research agencies that follow Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions (NASDAQ: MDRX) last published the quarterly results on Thursday 2 August. The software producer reported $ 0.18 earnings per share (EPS) for the quarter and met consensus analyst estimates of $ 0.18. Allscripts Healthcare Solutions had a net margin of 0.10% and a return on equity of 8.26%. The company had sales of $ 525.50 million during the quarter compared to the consensus estimate of $ 536.93 million. During the same quarter of the previous year, the company scored $ 0.15 EPS. The company's sales for the quarter increased by 23.3% compared to the same quarter last year.

A number of brokers recently released reports on MDRX. JPMorgan Chase & Co. began the coverage of shares of Allscripts Healthcare Solutions in a research report on Tuesday 24 April. They have an "overweight" rating and a price target of $ 16.00 for the company. ValuEngine increased shares of Allscripts Healthcare Solutions from a "sell" rating to a "hold" rating in a report on Thursday, August 2. BidaskClub reduced the shares of Allscripts Healthcare Solutions from a & # 39; hold & # 39; credit to a & # 39; sell & # 39; credit rating in a report on Wednesday, June 13th. Maxim Group confirmed a "buy" rating and gave a target price of $ 18.00 on shares of Allscripts Healthcare Solutions in a report on Friday, May 4. Finally, SunTrust Banks raised shares of Allscripts Healthcare Solutions from a hold & # 39; credit to a & # 39; buy & # 39; -rating and increased their target price for the shares from $ 10.78 to $ 16.13 in a report on Friday, May 4. They noted that the move was a valuation call. Four analysts have rated the shares with a hold rating and fourteen have assigned a buy-rating to the shares. The stock currently has a consensus rating of "Buy" and an average price target of $ 16.37.

In other Allscripts Healthcare Solutions news, CFO Dennis Olis sold 25,000 shares of the shares in a transaction on Thursday, August 16th. The shares were sold at an average price of $ 14.50, for a total transaction of $ 362,500.00. The transaction was announced in an application to the Securities & Exchange Commission, which is accessible through the SEC website. EVP Brian Farley also sold 5,000 shares of the shares in a transaction on Thursday 14 June. The shares were sold at an average price of $ 12.23, for a total transaction of $ 61,150.00. After the transaction, the Executive Vice President now holds directly 247,673 shares of the company's shares, valued at approximately $ 3,029,040.79. The information for this sale can be found here. In the past ninety days, Insiders sold a total of 45,000 shares of company shares worth $ 609,650. 1.10% of the stock is currently in the possession of insiders.

Institutional investors and hedge funds have recently increased or decreased their stake in the company. Summit Trail Advisors LLC acquired a new position in shares of Allscripts Healthcare Solutions in the second quarter of approximately $ 105,000. Mission Wealth Management LP bought a new position in shares of Allscripts Healthcare Solutions in the first quarter of approximately $ 135,000. Canandaigua National Bank & Trust Co. bought in the first quarter a new position in shares Allscripts Healthcare Solutions worth approximately $ 145,000. Connor Clark & ​​Lunn Investment Management Ltd. bought a new position in shares of Allscripts Healthcare Solutions worth approximately $ 160,000 during the second quarter. Finally, Whittier Trust Co. bought from Nevada Inc. a new position in shares of Allscripts Healthcare Solutions during the second quarter, worth approximately $ 229,000.

Shares of MDRX shares opened on Friday at $ 14.60. Allscripts Healthcare Solutions has a 1-year low of $ 10.78 and a 1-year high of $ 16.13. The company has a short ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 1.41. The company has a market capitalization of $ 2.39 billion, a PE ratio of 30.82, a price-earnings ratio of 1.79 and a beta of 1.09.

Allscripts Healthcare Solutions stated that on Thursday, August 2, the Board of Directors approved a share purchase program, allowing the company to repurchase $ 250 million in shares. This purchase authorization allows the software maker to purchase up to 11.3% of its shares through open market purchases. Share repurchases & # 39; s are generally a sign that the board of the company believes that the share is undervalued.

Allscripts Healthcare Solutions Company profile

Allscripts Healthcare Solutions, Inc. provides solutions and services for information technology to healthcare organizations in the United States, Canada and internationally. It offers electronic medical records, connectivity, private cloud hosting, outsourcing, analytics, patient involvement, clinical decision support and solutions for public health management.

Featured article: What is the NASDAQ?

Receive a free copy of the Zacks research report on Allscripts Healthcare Solutions (MDRX)

Visit Zacks.com for more information about research offers from Zacks Investment Research



Receive news and ratings for Allscripts Healthcare Solutions Daily – Please provide your email address below for a concise, daily summary of the latest news and ratings from analysts for Allscripts Healthcare Solutions and related companies with the FREE daily email newsletter from MarketBeat.com.


Source link

Leave a Reply